Viewing nowCombinationTelmisartan and Amlodipine Tablets 40/5mg (Telmisartan, Amlodipine)
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
TerraGen Etex Co., Ltd.

MFDS item code 201902736 · Approved 2019.04.29 · Insurance code 698504840
Treatment of essential hypertension not controlled with monotherapy
This medication is used to control the blood pressure of patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with Amlodipine or Telmisartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years and over, amlodipine clearance is decreased; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. Patients with allergies to any ingredients in this medication, as well as those with certain heart, liver, or kidney conditions, and women who are pregnant or breastfeeding should not take this medication. Patients with impaired liver or kidney function, valvular heart disease, or elderly patients require special caution when taking this medication. Common side effects may include dizziness and edema, and serious reactions have been reported rarely, so if any unusual symptoms occur, consult a healthcare professional immediately. Regular monitoring of blood pressure and blood tests is necessary due to risks such as hypotension, hyperkalemia, and changes in kidney function during administration. This medication may interact with other drugs, so it is essential to inform healthcare professionals of any currently used medications, particularly when taken with diuretics, lithium, digoxin, anticoagulants, and non-steroidal anti-inflammatory drugs. If pregnant, this medication should be discontinued as soon as possible, and if necessary, replaced with another safe drug. It is advisable for breastfeeding women to avoid this medication, and it is not recommended for children or adolescents under 18 years old. Elderly patients may be more sensitive to this medication, requiring dose adjustments and precautions. In case of overdose, symptoms such as hypotension, dizziness, and heart problems may occur, so immediate emergency treatment is required, and treatment should proceed according to the symptoms. This medication should be kept out of the reach of children, stored in a sealed state, and not transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a dark place, ideally at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the medication's effectiveness.
Biconvex oval double tablets in white and light gray color
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
TerraGen Etex Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.